United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Healthcare Industry News Thaumatin: The plant-based protein sweetener transforming the sugar alternative industry The demand for natural, healthier alternatives to refined sugar and artificial sweeteners continues to rise as consumers become… bypharmanewsdailyFebruary 23, 2025